The National Institutes of Health notified Ossium that its proposal to demonstrate that the pool of viable, deceased donors for bone marrow transplants includes tissue donors -- deceased donors who do not satisfy all of the health requirements of organ donors -- is likely to be accepted. The NIH's decision... read more →
Leading Tissue Processor AlloSource has signed a decade-long strategic partnership with Ossium Health. The partnership combines a 10-year tissue processing relationship with a substantial financial investment. The deal is expected to radically accelerate the development of Ossium's bone marrow bank and bolster AlloSource's already large donor tissue processing operations with... read more →
Leading venture capital firm First Round Capital -- early investors in Uber, Square, Flatiron Health and more than 250 other companies -- has backed Ossium Health. The San Francisco, New York, and Philadelphia based VC specializes in early stage companies, pairing its "seed investments" with a suite of company-building services... read more →
Dr. Erik Woods -- former President of the International Society for Cryobiology, Founder, President and CEO of General Biotechnology, and SVP & Lead Scientist of Cook Regentec -- joined Ossium Health as Co-Founder and Chief Science Officer this month, rounding out Ossium's founding team with deep scientific expertise.